NCT04008264View on ClinicalTrials.gov

A Novel Usage of Transdermal Scopolamine in Reducing Narcotic Usage in Outpatient Hand Surgery

CompletedOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

June 25, 2019

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions
Post Operative Pain Management
Interventions
DRUG

Scopolamine Patch (Transderm V)

During the observational phase, patients will be given a prescription for an 18 day supply of scopolamine, and patients will record the same data as prior to the intervention.

Trial Locations (1)

15213

Falk Clinic, 3601 Fifth Ave., Suite 6B, Pittsburgh

All Listed Sponsors
lead

Alexander M Spiess, MD

OTHER

NCT04008264 - A Novel Usage of Transdermal Scopolamine in Reducing Narcotic Usage in Outpatient Hand Surgery | Biotech Hunter | Biotech Hunter